APOB and fungal infectious disease: Altogether, the obtained findings indicate that ApoB-derived peptides represent novel antifungal agents suitable for the future development of effective strategies to treat fungal infections generally recalcitrant to conventional therapeutic approaches, also considering that they have been previously demonstrated to be neither toxic nor haemolytic for murine and human eukaryotic cell lines (Gaglione et al. 2017).